Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 5170 Reports

🤖 AI Analyzed

Recent

📄 Page 21 of 431

J.Jill, Inc.

10-K March 31, 2026

Key Highlights

Strong omnichannel model with customers spending 3x more than single-channel sho...
High loyalty engagement with private label credit cardholders accounting for 48%...
Shareholder-friendly capital allocation including increased dividends and a $25 ...

Read Analysis

🤖 AI Generated

CITIGROUP COMMERCIAL MORTGAGE TRUST 2016-P6

10-K March 31, 2026

Key Highlights

Trust is in its final maintenance phase, focusing on collecting payments until l...
Diversified risk profile with no single borrower exceeding 10% of the total loan...
Transition of master servicing to Trimont LLC aims to improve operational effici...

Read Analysis

🤖 AI Generated

Co-Diagnostics, Inc.

10-K March 31, 2026

Key Highlights

Developing the Co-Dx PCR platform for portable, smartphone-connected home testin...
Proprietary 'Co-Primers' technology offers potential for lower production costs ...
Secured significant grant funding from the Bill & Melinda Gates Foundation and N...

Read Analysis

🤖 AI Generated

Greater Cannabis Company, Inc.

10-K March 31, 2026

Key Highlights

Holds an exclusive global license from the Hebrew University of Jerusalem for un...
Targeting high-growth medical markets including autism, Parkinson’s, and Alzheim...
Executed a 1-for-1,500 reverse stock split to maintain exchange compliance and i...

Read Analysis

🤖 AI Generated

Rekor Systems, Inc.

10-K March 31, 2026

Key Highlights

Transitioning from hardware sales to a high-margin, recurring subscription model...
Successful 'land and expand' strategy securing multi-year government contracts.
Innovative 'concrete to cloud' AI technology that integrates with existing city ...

Read Analysis

🤖 AI Generated

CITIGROUP COMMERCIAL MORTGAGE TRUST 2017-P7

10-K March 31, 2026

Key Highlights

Successful transition of master servicing rights to Trimont LLC.
Stable operational performance with no major loan defaults reported.
Clear path to maturity for remaining loan pool through 2027.

Read Analysis

🤖 AI Generated

Cardiol Therapeutics Inc.

40-F March 31, 2026

Key Highlights

Lead drug candidate CardiolRx™ targets heart inflammation and scarring
Strong cash position of $48.5 million to fund ongoing clinical trials
Potential to become an acquisition target for major pharmaceutical firms upon cl...

Read Analysis

🤖 AI Generated

CLOUDASTRUCTURE, INC.

10-K March 31, 2026

Key Highlights

Secured contracts with six of the top ten U.S. property management firms.
Proprietary AI platform successfully stopped over 98% of threatening activity in...
Revenue grew by 50% year-over-year, reaching $4.2 million.

Read Analysis

🤖 AI Generated

CD 2017-CD5 MORTGAGE TRUST

10-K March 31, 2026

Key Highlights

Strong portfolio performance with a 0.00% delinquency rate across all major loan...
Backed by high-profile commercial assets including the General Motors Building a...
Transition to Trimont LLC as Master Servicer ensures professional oversight of d...

Read Analysis

🤖 AI Generated

CITIGROUP COMMERCIAL MORTGAGE TRUST 2017-B1

10-K March 31, 2026

Key Highlights

Mature CMBS trust with a successful track record of returning capital to investo...
Transition to Trimont LLC as master servicer ensures ongoing professional manage...
Provides predictable, bond-like cash flow payments derived from a pool of commer...

Read Analysis

🤖 AI Generated

CITIGROUP COMMERCIAL MORTGAGE TRUST 2017-P8

10-K March 31, 2026

Key Highlights

Consistent cash flow generation through a diversified pool of over 35 commercial...
Improved loan-to-value ratios since 2017 due to steady principal paydowns, provi...
Transition to Trimont LLC as master servicer ensures professional oversight of m...

Read Analysis

🤖 AI Generated

Catheter Precision, Inc.

10-K March 31, 2026

Key Highlights

Focus on high-growth $1 billion-plus heart mapping and surgery market.
Strategic acquisition of Cardionomics and Kardionav assets to expand IP.
Development of VIVO 3D imaging system for advanced heart rhythm care.

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage